Literature DB >> 5696221

A progress report on the Medical Research Council's therapeutic trial in myelomatosis.

D A Galton, R Peto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5696221

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  9 in total

1.  IgG myeloma presenting as ulcerative colitis.

Authors:  M R Haeney; I N Ross; R A Thompson; P Asquith
Journal:  J Clin Pathol       Date:  1977-09       Impact factor: 3.411

2.  Chemotherapy in the management of extramedullary plasmacytoma.

Authors:  E Wiltshaw
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

Review 3.  Immunocytoma o' mice an' men.

Authors:  J R Hobbs
Journal:  Br Med J       Date:  1971-04-10

4.  Paraproteinaemias. A laboratory survey.

Authors:  G Blundell; J E Fitzpatrick
Journal:  Ir J Med Sci       Date:  1971-04       Impact factor: 1.568

5.  Factors influencing the prognosis in myelomatosis.

Authors:  A A Dawson; D Ogston
Journal:  Postgrad Med J       Date:  1971-10       Impact factor: 2.401

6.  Management of multiple myeloma.

Authors:  J S Malpas
Journal:  Br Med J       Date:  1969-04-19

Review 7.  Management of paraproteinaemia.

Authors:  Lucy Cook; Donald H C Macdonald
Journal:  Postgrad Med J       Date:  2007-04       Impact factor: 2.401

8.  Hypercalcaemia due to the coexistence of parathyroid adenoma and myelomatosis.

Authors:  R M Francis; A G Bynoe; C Gray
Journal:  J Clin Pathol       Date:  1982-07       Impact factor: 3.411

9.  Myelomatosis: comparison of melphalan and cyclophosphamide therapy.

Authors: 
Journal:  Br Med J       Date:  1971-03-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.